CCA-1.1 破坏MYC蛋白质的稳定,在肝细胞癌中诱导不可逆转的抗增殖作用
Rohmad Yudi Utomo1,2, Novia Permata Hapsari3, Nadzifa Nugraheni3
1Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia. rohmad.yudi.utomo@ugm.ac.id.
Medical oncology (Northwood, London, England)
|December 2, 2025
概括
CCA-1.1通过向MYC蛋白质,抑制增殖,并诱导细胞死亡途径,如细胞亡和衰老,有效地对抗肝细胞癌 (HCC).
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- N-Myc和c-Myc是肝细胞癌 (HCC) 的关键驱动因素,促进癌细胞增殖,存活和代谢变化.
- 在HCC中MYC蛋白的过度表达与患者的不良结果相关,但它们的混乱结构阻碍了直接的药物向.
- 库尔库明的衍生物CCA-1.1,与其母化合物相比,显示出有前途的抗癌特性和增强的特性.
研究的目的:
- 为了研究CCA-1.1对HCC细胞的抗增殖作用.
- 探索CCA-1.1的作用机制,重点关注MYC蛋白调节和诱导细胞死亡.
- 评估CCA-1.1作为MYC驱动的HCC治疗剂的潜力.
主要方法:
- 在Huh-6细胞上进行细胞增殖测定.
- 细胞周期进展,细胞亡和衰老的分析.
- 西部涂抹以评估蛋白质水平 (N-Myc,c-Myc,NCYM) 和信号通路 (GSK3β).
- 分子对接和动态模拟以预测CCA-1.1与MYC蛋白的相互作用.
主要成果:
- CCA-1.1对Huh-6 HCC细胞表现出强大且不可逆转的抗增殖活性.
- CCA-1.1 抑制了EGFR激酶活性,并诱导了G2/M细胞周期停止,细胞亡和衰老.
- 通过激活GSK3β和抑制NCYM,CCA-1.1降低了N-Myc和c-Myc的调节,导致MYC蛋白的破坏稳定和自诱导.
- 分子建模证实了CCA-1.1与N-Myc和c-Myc的相互作用.
结论:
- 在MYCN表达HCC细胞中,CCA-1.1表现出多方面的抗癌作用.
- CCA-1.1通过抑制酶信号和破坏MYC蛋白质的稳定性而起作用,从而触发亡,衰老和自.
- CCA-1.1 是由MYC激活驱动的HCC的一个有希望的治疗候选者.
相关概念视频
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K


